Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
ACE2‐Fc Potential treatment - pre-clinical evidence Experimental Antiviral Apr/26/2022 5 0
Colchicine Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022 20 5
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
Adjuvanted SARS-CoV-2 Spike protein Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021 4 0
Quinacrine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 3 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0
Curcumin Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021 6 0
Catechin-gallocatechin-catechin Potential treatment - theoretical effect Natural product Antiviral Jan/21/2021 1 0
Excel (.xslx) CSV (.csv)